Aethlon Medical (AEMD) Stock Price, Quote & News

Company Profile

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

Industry: Medical Devices

Sector: Healthcare

Phone: 619 941 0360

Fax: 619 941 0361

Website: www.aethlonmedical.com

Address:

11555 Sorrento Valley Road, Suite 203, San Diego, United States

walker7782 Jan. 13 at 8:47 PM

$AEMD Painful - I'm out. Scaled out so I didn't dump on the ask. Had to lock 10% profits if I could on a day like today...good luck!

0 · Reply

walker7782 Jan. 13 at 4:13 PM

$AEMD Still holding 2.39 average

0 · Reply

QuantumSwings Jan. 12 at 6:15 PM

$AEMD Has one more run in it before next R/S imo.

0 · Reply

ChartChartist Jan. 10 at 11:49 PM

$NDRA like $SSM welp, pump it $AEMD sad its so good tho $BOXL 775k is good volume but $$$$$. $HWH $$$$$$$ dis is da one Top play next week

0 · Reply

UNCLE_SCROOGE_ Jan. 8 at 4:55 PM

$AEMD Oh, finally this scam company is about to go bankrupt. Thank God.☺️

0 · Reply

kellys2025 Jan. 7 at 8:49 PM

$AEMD Attached is a newly published peer-reviewed paper in BMJ Open outlining the scientific rationale and design of the Australian Clinical Trial of the Aethlon Hemopurifier in Oncology : https://bmjopen.bmj.com/content/16/1/e102581.full

0 · Reply

Waffels Jan. 7 at 12:00 AM

$AEMD i always like this. my mom could use 5 hemopurifier right now

1 · Reply

OPTIONTURD Dec. 31 at 8:30 PM

$AEMD They need to sell their great product to Hospitals, Doctors, ER'S, ETC. Hasn't it been a proven filter? Profits, more profits, and more profits and it could be a $50/share company. All this research money and investor's money is only paying for salaries and research. Get off the pot and go.

2 · Reply

GPSGlow Dec. 27 at 5:24 PM

$AEMD Investors are weighing durability against tactical noise; commercial execution has to tighten in upcoming quarters — clear evidence of repeatability would change the narrative. Markets will follow data, not narratives.

0 · Reply

ChartChartist Dec. 27 at 3:41 PM

$AEMD so ready

0 · Reply

Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million

Dec 2, 2025, 8:01 AM EST - 6 weeks ago

Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs

Nov 12, 2025, 6:31 PM EST - 2 months ago

Aethlon Medical, Inc. (AEMD) Q2 2026 Earnings Call Transcript

Nov 12, 2025, 4:15 PM EST - 2 months ago

Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update

Nov 7, 2025, 8:01 AM EST - 2 months ago

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025

Oct 7, 2025, 8:01 AM EDT - 3 months ago

Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial

Sep 4, 2025, 9:15 AM EDT - 4 months ago

Aethlon Medical Announces Pricing of $4.5 Million Public Offering

Sep 3, 2025, 8:01 AM EDT - 4 months ago

Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)

Aug 13, 2025, 8:01 PM EDT - 5 months ago

Aethlon Medical, Inc. (AEMD) Q1 2026 Earnings Call Transcript

Aug 13, 2025, 4:15 PM EDT - 5 months ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update

Aug 5, 2025, 8:01 AM EDT - 5 months ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025

Jul 15, 2025, 8:01 AM EDT - 6 months ago

Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort

Jun 26, 2025, 7:35 PM EDT - 7 months ago

Aethlon Medical, Inc. (AEMD) Q4 2025 Earnings Call Transcript

Jun 26, 2025, 4:15 PM EDT - 7 months ago

Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update

Jun 20, 2025, 8:01 AM EDT - 7 months ago

Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025

Jun 18, 2025, 8:01 AM EDT - 7 months ago

Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial

Jun 9, 2025, 8:01 AM EDT - 7 months ago

Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes

May 14, 2025, 8:01 AM EDT - 8 months ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma

Mar 10, 2025, 8:01 AM EDT - 11 months ago

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

Feb 13, 2025, 8:01 AM EST - 11 months ago

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

Feb 12, 2025, 8:11 PM EST - 11 months ago

Aethlon Medical, Inc. (AEMD) Q3 2025 Earnings Call Transcript

Feb 12, 2025, 4:15 PM EST - 11 months ago

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

Feb 5, 2025, 8:01 AM EST - 1 year ago

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

Jan 29, 2025, 8:01 AM EST - 1 year ago

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

Dec 20, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

Nov 14, 2024, 8:00 AM EST - 1 year ago

Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

Nov 13, 2024, 7:58 PM EST - 1 year ago

Aethlon Medical, Inc. (AEMD) Q2 2025 Earnings Call Transcript

Nov 13, 2024, 4:15 PM EST - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

Nov 12, 2024, 8:00 AM EST - 1 year ago

Innovative Medical Technology Advances with First Patient Enrollments

Nov 11, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

Nov 6, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

Oct 8, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 19, 2024, 10:00 AM EDT - 1 year ago

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Sep 19, 2024, 8:01 AM EDT - 1 year ago

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Sep 17, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Present at Virtual Investor Conferences in September

Sep 17, 2024, 7:30 AM EDT - 1 year ago

Innovation Driving Cancer's Solid Tumors Market

Sep 16, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

Sep 13, 2024, 8:35 AM EDT - 1 year ago

Aethlon Medical to Present at the Life Sciences Investor Forum September 19th

Aug 27, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

Aug 14, 2024, 6:45 PM EDT - 1 year ago

Aethlon Medical, Inc. (AEMD) Q1 2025 Earnings Call Transcript

Aug 14, 2024, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update

Aug 12, 2024, 9:01 AM EDT - 1 year ago

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

Aug 12, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

Aug 6, 2024, 9:12 AM EDT - 1 year ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

Jun 27, 2024, 6:37 PM EDT - 1 year ago

Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Call Transcript

Jun 27, 2024, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

Jun 21, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

Jun 20, 2024, 7:00 AM EDT - 1 year ago

What's Next in Treatments for Cancer Patients with Solid Tumors?

Jun 18, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

Jun 7, 2024, 8:00 AM EDT - 1 year ago

The Hunt for Virus Treatments Continues Post Covid-19

walker7782 Jan. 13 at 8:47 PM

$AEMD Painful - I'm out. Scaled out so I didn't dump on the ask. Had to lock 10% profits if I could on a day like today...good luck!

0 · Reply

walker7782 Jan. 13 at 4:13 PM

$AEMD Still holding 2.39 average

0 · Reply

QuantumSwings Jan. 12 at 6:15 PM

$AEMD Has one more run in it before next R/S imo.

0 · Reply

ChartChartist Jan. 10 at 11:49 PM

$NDRA like $SSM welp, pump it $AEMD sad its so good tho $BOXL 775k is good volume but $$$$$. $HWH $$$$$$$ dis is da one Top play next week

0 · Reply

UNCLE_SCROOGE_ Jan. 8 at 4:55 PM

$AEMD Oh, finally this scam company is about to go bankrupt. Thank God.☺️

0 · Reply

kellys2025 Jan. 7 at 8:49 PM

0 · Reply

Waffels Jan. 7 at 12:00 AM

$AEMD i always like this. my mom could use 5 hemopurifier right now

1 · Reply

OPTIONTURD Dec. 31 at 8:30 PM

2 · Reply

GPSGlow Dec. 27 at 5:24 PM

0 · Reply

ChartChartist Dec. 27 at 3:41 PM

$AEMD so ready

0 · Reply

LoomLapidary Dec. 26 at 5:22 PM

$AEMD Price action signals that reliability now matters more than headline momentum. Margin trajectory needs to confirm that scale creates leverage, not dilution. Clear execution would attract broader institutional participation. Execution quality will determine whether momentum is sustainable.

0 · Reply

Bazzzigar Dec. 25 at 8:17 PM

$AEMD JUNK

0 · Reply

FilingTracker Dec. 23 at 8:08 PM

$AEMD Offering - Up to $15M: https://www.sec.gov/Archives/edgar/data/882291/000168316825009335/aethlon_s3.htm

0 · Reply

ChartChartist Dec. 10 at 8:32 PM

$AEMD hard to fill on bid today, ready $MRNO ready , nano float with one short. No volume yet

1 · Reply

TheSniperGuy Dec. 8 at 9:36 PM

$WBUY $49 soon, $CETX test $20 again prob tomorrow or Wednesday, $AEMD back to October's high $9. $LITM -- diamond in the making $30+

0 · Reply

TheSniperGuy Dec. 8 at 9:11 PM

$CETX $WBUY $AEMD My LOTTO tickets, 150$ each, let's go! 💪🏻

0 · Reply

ACInvestorBlog Dec. 8 at 2:35 PM

$AEMD another low float on watch.

0 · Reply

BearTamerTrading Dec. 6 at 2:17 AM

🌙 After-Hours Alerts — Bear Tamer Trading 🔥 $AEMD — Low-float biotech showing steady AH interest. These names can spike quickly when bidders step up, especially after periods of consolidation. 🔥 $HWH — Alset/HWH International ripping after-hours with strong momentum. Recent corporate restructurings + thin supply make it a high-volatility mover. 🔥 $CETY — Clean energy micro-cap stabilizing after a sharp intraday drop. Traders watching for a reclaim setup into tomorrow. 🔥 $MTVA — Huge after-hours surge as early-stage tech names continue attracting speculative flow. Low market cap + sudden volume = explosive potential. 🔥 $TWG — Financial/wealth-management low-float play showing an AH breakout. Thin floats like this move fast when volume rotates in. Huge congrats to everyone who ate during after-hours today 💰👏 Here’s the proof — all alerted live ⬇️ 🔗 https://www.youtube.com/live/bPl7alEHg9I?si=70cjB4T5amPJFwhR Rest up, we do it again tomorrow. 🚀

0 · Reply

RAIK7 Dec. 5 at 11:05 PM

$AEMD Wow, thanks for uick profit! :-D

0 · Reply

DaBullRunner Dec. 5 at 10:53 PM

$TGL BIG MONEY is being made here 👇💰💰💰💰 🚨LRHC🚨slowly adding the dips nano floater with a history of MONSTER runs and JUST HAD SOLID NEWS $BDRX $MTVA $AEMD $TWG watching closely

0 · Reply

DaBullRunner Dec. 5 at 10:51 PM

$RUBI there it goes BIG MONEY was made here 👇💰💰💰💰 🚨LRHC🚨slowly adding the dips nano floater with a history of MONSTER runs and JUST HAD SOLID NEWS $SUGP $MTVA $AEMD $TWG watching closely

0 · Reply

ChartChartist Dec. 5 at 10:48 PM

$AEMD been calling this in the room $MRNO calling this now

0 · Reply

Market Cap	2.32M
Revenue (ttm)	0.00
Net Income (ttm)	-13.39M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	131,200
Avg Vol	134,560
Day's Range	N/A - N/A
Shares Out	973,000.00
Stochastic %K	43%
Beta	1.60
Analysts	Hold
Price Target	$9.75